<DOC>
	<DOCNO>NCT01644591</DOCNO>
	<brief_summary>The goal clinical research study find stereotactic radiosurgery ( SRS ) control disease patient 3 melanoma brain tumor . SRS delivery focus , high-dose radiation give single session tumor minimal dose give uninvolved area brain .</brief_summary>
	<brief_title>Trial Determine Local Control Neurocognitive Preservation After Initial Treatment With Stereotactic Radiosurgery ( SRS ) Patients With &gt; 3 Melanoma Brain Metastases</brief_title>
	<detailed_description>Study Procedure : You receive SRS Day 1 . There 1 day treatment . You sign separate consent form SRS explain procedure risk detail . Study Visits : At 1 , 6 , 9 month ( +/- 14 day ) Day 1 , follow test procedure perform : - You physical exam , include measurement vital sign . - You MRI check status disease . - You complete 8 cognitive function test 3 questionnaire complete screening . At 4 12 month ( +/- 14 day ) Day 1 , follow test procedure perform : - You physical exam , include measurement vital sign . - You MRI check status disease . - You whole body PET scan check status disease check effect disease think brain function . - You complete 8 cognitive function test 3 questionnaire complete screening . If disease return treatment , may receive additional SRS . Your treatment option discuss . Length Study Participation : Your active participation study complete Month 12 visit . If MRI scan show 15 lesion , withdrawn study . Your doctor ( ) discuss future treatment option . Follow-Up Visits : If study doctor think need , return clinic follow-up visit . The following test procedure perform : - You physical exam , include measurement vital sign . - You ask drug may take . - You MRI check status disease . This investigational study . Up 49 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>1 . All patient histologic proof malignant melanoma . Histologic confirmation may primary tumor site , another metastatic site ( systemic lymph node , etc ) . Cytologyalone acceptable method diagnosis . 2 . Greater 3 presume melanoma brain metastasis contrastenhanced brain MRI scan obtain great 4 week prior study registration 3 . Patients must age &gt; /= 18 year . 4 . Patients must sign informed consent indicate aware investigational nature study keep policy hospital . 5 . Patients must KPS &gt; /=70 6 . Patients must eligible lesion treat determine study radiation oncologist . 7 . Patients must adequate renal/hematologic function , define creatinine clearance &gt; 30ml/min platelet &gt; 50,000 . 8 . Patients normal coagulation [ International Normalized Ratio ( INR ) &lt; 1.3 ] able withhold anticoagulation/antiplatelet medication minimum 24 hour prior radiosurgery treatment ( INR normalizes ) , day treatment 24 hour radiosurgery treatment conclude . 9 . Patients undergoing concurrent systemic therapy , temozolomide , discretion treat oncologist . 1 . Patients exclude treated whole brain radiotherapy within prior 3 month . 2 . Patients exclude history metastatic cancer addition melanoma history uncontrolled nonmetastatic cancer . Patients localize squamous cell carcinoma and/or basal cell carcinoma exclude . 3 . Patients exclude radiographic cerebrospinal fluid ( CSF ) evidence leptomeningeal disease . 4 . Female patient childbearing age exclude pregnant determine serum beta HCG great 14 day prior study registration , breastfeed . ( The exclusion make gadolinium may teratogenic pregnancy ) . 5 . Patients exclude history gadolinium allergy . 6 . Patients exclude unable obtain Magnetic resonance imaging ( MRI ) scan reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Malignant melanoma</keyword>
	<keyword>Brain Metastases</keyword>
	<keyword>Stereotactic Radiosurgery</keyword>
	<keyword>SRS</keyword>
	<keyword>XRT</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>